Grant Opportunity - AFib Screening Initiative: Apply by May 29, 2017

Afib Screening Initiative

The Heart Rhythm Society will select up to eight applicants to conduct AFib screenings which target individuals who have  AFib risk factors and common co-morbidities. 

Selected facilities will be awarded:

  • $20,000 USD grant to support their AFib screening protocol and reporting
  • 250 HRS AFib Patient Brochures
  • Two AFib screening devices for up to one year (AliveCor Kardia units)

Screenings must occur between August 2017 and January 2018. This opportunity is open to HRS members within the U.S. The submission deadline is May 29, 2017 at 11:59 p.m. ET.

Apply Now

About the Program

The HRS AFib screening and education program aims to identify patients with undiagnosed AFib while informing patients and caregivers about the risks associated with AFib and Stroke. The program will target those suffering from common AFib co-morbidities or those showing signs of common risk factors, for example, diabetes and sleep apnea. The program will also work to identify, screen and educate patients at the point of care or in partnership with appropriate clinics and/or organizations (e.g. pharmacies, senior centers) at the local level.

The goals of this project are to:

  • Increase awareness of AFib screening
  • Increase AFib awareness to patients and caregivers
  • Collect non-scientific data including:
    • the number of patients screened
    • location of screening
    • limited patient statistics (age, sex, comorbidity, risk factors)
    • number of ‘positive’ screenings.


  • An HRS member must be the award’s primary contact
  • A minimum of 250 eligible patients must be screened over the award’s project term
  • Ability to comply with reporting requirements 

Screening requirements—eligible patients:

  • Must not have a pre-diagnosis of AFib
  • Must have at least TWO of the following risk AFib risk factors:
    • Sleep Apnea
    • Peripheral vascular disease
    • Diabetes
    • Obesity
    • Hypertension
    • Female sex
    • Greater than 75 years old

Basis for Award Selection

The following criteria will be used to award the contract:

  • Completion of the RFA in full prior to the submission deadline
  • Thoroughness of the submission and screening method/implementation plans.
  • Location/type of the site and statistical probability that positive screenings will result
  • Advisory panel confidence in the management of the project based on the implementation plan provided.
Apply Now


The AFib Screening Initiative has been made possible through a grant from the Bristol Myers-Squibb/Pfizer Alliance.

BMS Pfizer logo 2017

About AFib

Atrial Fibrillation (AF) is a common and serious cardiovascular disease associated with significant morbidity and mortality. AF is the most common arrhythmia in the United States, affecting more than 2.7 million adults. In the next 40 years, the prevalence of AF is projected to more than double. AF accounts for approximately one- third of hospitalizations for cardiac rhythm disturbances. Even though risk factors and serious complications of AF are well known, AF has not received the same attention as other chronic conditions to improve screening, diagnosis, treatment and prevention. The Heart Rhythm Society (HRS) is committed to increasing awareness of this serious and relatively under diagnosed health condition and to improving the care of patients living with AF.

Questions and Inquiries

Questions should be addressed to